About Zinc finger imprinted 3
Zinc finger imprinted 3 (ZIM3) is a protein
from Homo sapiens identified by UniProt accession
Q96PE6, 472 residues long.
MolForge cross-references it against 0 known binders and
12 disease associations.
Target properties
| Protein name | Zinc finger imprinted 3 |
| UniProt accession | Q96PE6 |
| Gene | ZIM3 |
| Organism | Homo sapiens |
| Length | 472 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (12)
Diseases linked to this target (Open Targets).
- neurodegenerative disease · score 0.17
- IGF-1 measurement · score 0.09
- gut microbiome measurement · score 0.08
- triglyceride measurement · score 0.07
- high density lipoprotein cholesterol measurement · score 0.07
- osteosarcoma · score 0.02
- appendicular lean mass · score 0.02
- neoplasm · score 0.00
- Duodenal Adenocarcinoma · score 0.00
- T-cell acute lymphoblastic leukemia · score 0.00
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q96PE6-F1 | alphafold | PREDICTED | 75.18 | — |
Amino-acid sequence (472 residues)
MNNSQGRVTF EDVTVNFTQG EWQRLNPEQR NLYRDVMLEN YSNLVSVGQG ETTKPDVILR LEQGKEPWLE EEEVLGSGRA EKNGDIGGQI WKPKDVKESL AREVPSINKE TLTTQKGVEC DGSKKILPLG IDDVSSLQHY VQNNSHDDNG YRKLVGNNPS KFVGQQLKCN ACRKLFSSKS RLQSHLRRHA CQKPFECHSC GRAFGEKWKL DKHQKTHAEE RPYKCENCGN AYKQKSNLFQ HQKMHTKEKP YQCKTCGKAF SWKSSCINHE KIHNAKKSYQ CNECEKSFRQ NSTLIQHKKV HTGQKPFQCT DCGKAFIYKS DLVKHQRIHT GEKPYKCSIC EKAFSQKSNV IDHEKIHTGK RAYECDLCGN TFIQKKNLIQ HKKIHTGEKP YECNRCGKAF FQKSNLHSHQ KTHSGERTYR CSECGKTFIR KLNLSLHKKT HTGQKPYGCS ECGKAFADRS YLVRHQKRIH SR
Explore Zinc finger imprinted 3 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets